Skip to main content

Table 1 Patient characteristics

From: Differential expression of prolyl hydroxylase 1 in patients with ulcerative colitis versus patients with Crohn’s disease/infectious colitis and healthy controls

Group

Healthy controls

UC inflamed

UC remission

CD inflamed

CD remission

Infectious colitis

N (Biopsies)

20

16

5

19

10

9

Gender (male/female)

5/15

8/8

4/1

8/11

4/6

6/3

Age, years (mean)

49

38

50

32

49

36

Age, years (range)

12-73

14-58

26-70

11-54

28-73

17-58

Age at diagnosis

      

A1/A2/A3

 

1/9/6

0/4/1

4/11/4

0/6/4

 

Max location of disease

      

L1/L2/L3/L3 + L4/L4

   

0/7/9/3/0

3/2/4/0/1

 

E1/E2/E3

 

3/10/3

0/4/1

   

Max disease behaviour

      

B1/B2/B3

   

12/3/4

4/3/3

 
    

(9P)

(4P)

 

Medication

      

No

20

5

3

13

8

9

5-aminosalicylates

 

11

2

6

2

 
  1. CD: Crohn’s disease; UC: ulcerative colitis; A1: 0-16yrs, A2: 16-40yrs, A3: >40 yrs. Location of disease in and disease behavior of CD was defined as maximal disease before surgical resection; L1: solely ileal disease, L2: solely colonic disease, L3: ileal and colonic disease, L3 + L4: ileal, colonic and upper gastrointestinal tract disease, L4: upper gastrointestinal tract disease; B1: non-stricturing, non-penetrating, B2: stricturing, B3: penetrating, (Xp): number of patients when concomitant perianal disease was present; E1: ulcerative proctitis, E2: left-sided UC, E3: pancolitis.